Clinical Report: Correlation Between PIRCHE Scores and Allograft Damage in Recipients of Kidney Transplants

Overview

This study evaluates the association between PIRCHE scores and early allograft injury in kidney transplant recipients. Higher PIRCHE-T2 and PIRCHE-B scores correlate with increased risk of alloimmune injury, highlighting their potential role in risk stratification.

Background

Early allograft injury significantly impacts long-term graft survival in kidney transplantation. Understanding the immunological risks associated with donor-derived HLA peptides can aid in predicting and preventing these injuries. PIRCHE scores provide a novel approach to assess alloimmune risk beyond traditional HLA mismatch.

Data Highlights

Key Findings

• 37% of kidney transplant recipients experienced early allograft injury.
• Higher PIRCHE-T2 and PIRCHE-B scores are significantly associated with increased risk of composite allograft injury.
• PIRCHE-B scores improved prediction for donor-specific antibody (DSA) development compared to traditional HLA mismatch models.
• Both PIRCHE scores showed modest discriminatory performance with AUC values between 0.575 and 0.621.
• Higher PIRCHE scores correlate with increased risk of de novo or recurrent DSA and elevated donor-derived cell-free DNA.

Clinical Implications

Clinicians should consider incorporating PIRCHE scores into their risk assessment strategies for kidney transplant recipients. This may enhance the ability to predict early allograft injury and tailor immunosuppressive therapies accordingly.

Conclusion

The study underscores the relevance of PIRCHE scores in assessing alloimmune risk in kidney transplantation, suggesting their potential role in improving long-term graft outcomes.

Related Resources & Content

1. Suboptimal early graft performance negatively affects long-term results in living donor kidney transplants, 2012 -- https://link.springer.com/article/10.1007/s00345-012-0835-z
2. Chronic Inguinal Discomfort Following Kidney Transplantation: A Frequently Overlooked Concern, 2016 -- https://link.springer.com/article/10.1007/s00268-016-3713-9
3. Evaluation of Intraoperative Renal Blood Flow Using Transit Time Flow Measurements in Kidney Transplantation from Living and Deceased Donors, 2025 -- https://link.springer.com/article/10.1007/s13304-025-02344-5
4. European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study - PMC, 2024 -- https://pmc.ncbi.nlm.nih.gov/articles/PMC11043529/?utm_source=openai
5. De novo donor-specific HLA antibody development after kidney transplantation is impacted by PIRCHE II score and recipient age, 2025 -- https://public-pages-files-2025.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1508586/pdf
6. Suboptimal early graft performance negatively affects long-term results in living donor kidney transplants
7. Chronic Inguinal Discomfort Following Kidney Transplantation: A Frequently Overlooked Concern
8. Updates in Surgery — Evaluation of Intraoperative Renal Blood Flow Using Transit Time Flow Measurements in Kidney Transplantation from Living and Deceased Donors
9. Kidney Transplantation After Iliac Revascularization in Patients with Severe Atherosclerosis: A Comparative Analysis
10. European Society for Organ Transplantation Guidelines, 2024
11. PIRCHE and Alloimmune Risk in Kidney Transplantation, 2025
12. De novo donor-specific HLA antibody development after kidney transplantation is impacted by PIRCHE II score and recipient age
13. Frontiers | De Novo donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment
14. Journal of the American Society of Nephrology